SNNVF (Sunniva) Common Stock: $89.81 Mil (As of Sep. 2019)


What is Sunniva Common Stock?

Sunniva SNNVF -99.00% Common Stock is $89.81 Mil as of Sep. 2019.

Sunniva's quarterly common stock increased from Mar. 2019 ($87.09 Mil) to Jun. 2019 ($88.70 Mil) and increased from Jun. 2019 ($88.70 Mil) to Sep. 2019 ($89.81 Mil).

Sunniva's annual common stock increased from Dec. 2016 ($17.85 Mil) to Dec. 2017 ($41.90 Mil) and increased from Dec. 2017 ($41.90 Mil) to Dec. 2018 ($84.36 Mil).


Sunniva Common Stock Historical Data

* Premium members only.

The historical data trend for Sunniva's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunniva Common Stock Chart

Sunniva Annual Data
Trend Dec16 Dec17 Dec18
Common Stock
17.85 41.90 84.36

Sunniva Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.94 84.36 87.09 88.70 89.81

Sunniva Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $89.81 Mil mean?
Sunniva (SNNVF) has a Common Stock of $89.81 Mil as of Sep. 2019. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Sunniva and its competitors.
Is Sunniva's Common Stock too high?
Sunniva's current Common Stock is $89.81 Mil.
How does Sunniva's Common Stock compare to ZTS?
Sunniva's Common Stock of $89.81 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Sunniva and its competitors. Sunniva's current Common Stock is $89.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunniva stock overvalued right now?
Sunniva (SNNVF) has a current Common Stock of $89.81 Mil. The current Common Stock is $89.81 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Sunniva (SNNVF), the current Common Stock is $89.81 Mil as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunniva Business Description

Address 200 Burrard Street, 1200 Waterfront Centre, P.O Box 48600, Vancouver, BC, CAN, V7X 1T2
Sunniva Inc is vertically integrated medical cannabis company committed to delivering safe, low-cost, high-quality products and services at scale. The company is focused on the cultivation, production and distribution of therapeutic solutions targeting two of the medical cannabis markets in the world: Canada and California.